We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05219513
Brief Title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

First Submitted : November 23, 2021
First Submitted that Met QC Criteria : January 20, 2022
First Posted : February 2, 2022

Last Update Submitted that Met QC Criteria : March 16, 2023
Last Update Posted : March 20, 2023